Algernon Pharmaceuticals Inc.
Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.
Algernon Pharmaceuticals Inc. (AGN)
Le 18 novembre/November 2021
Algernon Pharmaceuticals Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every one hundred (100) pre-consolidated common shares.
As a result, the outstanding shares of the company will be reduced to approximately 1,678,809 common shares.
The name and symbol will not change.